Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines

COVID-19 Clinical Trials Immunology Public Engagement Recruitment Research Vaccinology

A pioneering study into human immunity is being launched today by Oxford Vaccine Group at the University of Oxford. The study, called LEGACY03, is being funded by the Medical Research Council part of UK Research and Innovation. By investigating how lymph nodes work, and how they make responses to vaccines in younger and older people, it has the potential to improve vaccine design for different age groups significantly.

Oxford COVID-19 vaccine begins human trial stage

COVID-19 Recruitment Research Vaccinology

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine.

Pregnant women invited to take part in pioneering diabetes prevention research

Clinical Trials Parents & Carers Recruitment Research

Dr Matthew Snape leads a study investigating if giving small amounts of oral insulin to babies can prevent type 1 diabetes, thus allowing mothers to protect their children from injecting insulin.

Amy Davis (pictured with fiancé Matt Jenkins), who was 18 when she fell ill with meningococcal B septicaemia in 2011. Amy received urgent medical treatment which saved her life. During a long recovery period it was clear that septicaemia had affected Amy’s arms and legs and she later had to have her left leg amputated below the knee. Amy has welcomed a University of Oxford study, supported by the NHS, to see whether giving a group B meningococcal (MenB) vaccine to teenagers could help protect all ages from the potentially fatal infection. Photo credit: Meningitis Research Foundation.

Oxford Vaccine Group leads meningitis vaccine trial for teenagers

Clinical Trials Recruitment Research Vaccinology

Researchers are working with schools around the county to find 24,000 volunteers aged 16 to 18 years to take part in the Be on the TEAM (Teenagers Against Meningitis) trial, led by the Oxford Vaccine Group at the Oxford University's Paediatrics Department with funding and support from the National Institute for Health Research (NIHR).